In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding

ANNALS OF INTERNAL MEDICINE（2023）

引用 0|浏览0

暂无评分

摘要

Source Citation Gragnano F, Cao D, Pirondini L, et al; PANTHER Collaboration. P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events. J Am Coll Cardiol. 2023;82:89-105. 37407118

查看译文

关键词

aspirin monotherapy,p2y12 inhibitor,major bleeding,composite cv outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要